Evolus Inc share price logo

Evolus Inc Share Price

NASDAQ: EOLS

Small Cap

$4.96

+0.04

(+0.71%)

Live

as on

Evolus Inc Stock Performance

as on April 23, 2026 at 3:12 am IST

  • Day's Low

    Day's High

    $4.85
    $5.03
    downward going graph

    2.22%

    Downside

    1.41%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.86
    $12.28
    downward going graph

    22.18%

    Downside

    147.58%

    Upside

    downward going graph

Evolus Inc share price movements today

Previous Close
$4.93
Open
$4.97
Volume
417.5K
Day's Low - High
$4.85 - $5.03
52 Week Low - High
$3.86 - $12.28

Evolus Inc Historical Returns

1 Month Return
+ 6.25 %
3 Month Return
-2.95 %
1 Year Return
-52.87 %
3 Year Return
-46.12 %
5 Year Return
-48.16 %

Evolus Inc Stock Fundamentals & Key Indicators

Check Evolus Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$320.7M

EPS (TTM)

-0.122

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-30.1M

Revenue (TTM)

297.2M

Profit Margin

-17.38%

Return On Equity TTM

-18729.61%

Evolus Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evolus Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Evolus Inc image
Evolus Inc
BUY$320.7M-48.16%NA-17.38%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$25.1BNA20.5841.94%
Viatris Inc image
Viatris Inc
HOLD$17.3B10.25%NA-24.58%
Haleon plc image
Haleon plc
BUY$42.4BNA19.0615.11%
Zoetis Inc image
Zoetis Inc
BUY$49.9B-30.1%20.3828.24%

Stock Returns calculator for Evolus Inc Stock including INR - Dollar returns

The Evolus Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Evolus Inc investment value today

Current value as on today

₹52,203

Returns

-₹47,797

(-47.8%)

Returns from Evolus Inc Stock

-₹52,581 (-52.58%)

Dollar Impact

₹4,785 (+4.78%)

Analyst Recommendation on Evolus Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Evolus Inc. Average target price of $14.67

Evolus Inc Share Price Target

Get share price movements and forecasts by analysts on Evolus Inc.

What analysts predicted

66.19%UPSIDE

Target Price

$14.67

Current Price

$4.96

Analyzed by

14 Analysts

Target

$14.67

Evolus Inc target price $14.67, a slight upside of 66.19% compared to current price of $4.96. According to 14 analysts rating.

Evolus Inc Stock’s Investor Sentiment and Interest

Search interest for Evolus Inc Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-26% versus previous 30 day period

Evolus Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
50
60
59
66
61
78
68
69
68
90
Gross Profit
34
38
40
47
42
50
46
45
45
57
Operating Income
-13
-8
-8
-7
-15
-2
-15
-10
-11
0
EBITDA
-11
-3
-6
-5
-13
0
-12
-7
-9
2
Interest Expense
3
4
4
4
4
4
4
7
4
3
Depreciation
1
1
1
1
1
1
1
2
2
2
Income Before Tax
-16
-11
-13
-11
-19
-6
-18
-17
-15
0
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-16
-11
-13
-11
-19
-6
-18
-17
-15
0
Net Profit Margin
-33.83%
-19.40%
-22.09%
-16.96%
-31.38%
-8.60%
-27.57%
-24.70%
-22.82%
0.14%

Evolus Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
34
56
99
148
202
266
297
Gross Profit
0
0
-
26
38
56
89
140
182
192
Operating Income
-19
-11
-46
-98
-153
-44
-65
-49
-34
-37
EBITDA
-19
-11
-45
-92
-144
-39
-53
-41
-25
-28
Interest Expense
-
-
0
7
10
1
9
13
18
19
Depreciation
-
0
0
5
7
6
4
5
6
8
Income Before Tax
-19
-11
-46
-105
-162
-46
-74
-61
-49
-50
Income Tax Expense
0
-7
0
-15
0
0
0
0
0
0
Net Income
-20
-4
-46
-90
-163
-46
-74
-61
-50
-51
Net Profit Margin
0.00%
0.00%
0.00%
-257.79%
-288.31%
-46.96%
-50.07%
-30.52%
-18.94%
-17.38%

Evolus Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-11
-13
-11
-19
-6
-18
-17
-15
0
Operating Cash Flow
0
-10
-6
-5
4
-15
-24
-14
12
Investing Cash Flow
0
0
-1
-1
-1
-1
-2
-2
-2
Financing Cash Flow
23
45
4
-1
-1
-1
20
-1
0
Change in Cash
24
34
-3
-8
1
-19
-6
-18
10

Evolus Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-46
-90
-163
-46
-74
-61
-50
-51
Operating Cash Flow
-13
-25
-93
-57
-33
-84
-34
-17
-42
Investing Cash Flow
0
0
-23
12
4
-2
-1
-4
-8
Financing Cash Flow
13
118
133
38
73
-4
44
47
17
Change in Cash
0
93
16
-7
43
-92
8
24
-33

Global Institutional Holdings in Evolus Inc

Funds
Holdings
Rice Hall James & Associates, LLC
1.77%
Altium Capital Management, LP
0.46%
UBS Group AG
1.58%
Renaissance Technologies Corp
1.23%
BlackRock Inc
6.88%
See all

Insights on Evolus Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -18.89M → 130.0K (in $), with an average increase of 4074.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, EOLS stock has moved up by 6.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 68.96M → 90.3M (in $), with an average increase of 23.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 95.8% return, outperforming this stock by 148.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 148.5% return, outperforming this stock by 194.6%

About Evolus Inc

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
OrganisationEvolus Inc
Headquarters520 Newport Center Drive, Newport Beach, CA, United States, 92660
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. David Moatazedi
E-voting on sharesClick here to vote

Key Management of Evolus Inc

Name

Title

Ms. Jessica Novak

Senior Vice President of Human Resources

Mr. David Moatazedi

President, CEO & Director

Ms. Tomoko Yamagishi-Dressler

Chief Marketing Officer

Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.

Chief Medical Officer and Head of Research & Development

Ms. Tatjana Mitchell

Chief Financial Officer

Mr. Nareg Sagherian

Head of Global Investor Relations & Corporate Communications

Mr. Jeffrey J. Plumer

General Counsel

Mr. Kurt Knab

Senior Vice President of Sales

FAQs

What is Evolus Inc share price today?

Evolus Inc share price today is $4.96 as on . Evolus Inc share today touched a day high of $5.03 and a low of $4.85.

What is the 52 week high and 52 week low for Evolus Inc share?

Evolus Inc share touched a 52 week high of $12.28 on and a 52 week low of $3.86 on . Evolus Inc stock price today i.e. is trending at $4.96,which is 59.61% down from its 52 week high and 28.50% up from its 52 week low.

What is Evolus Inc's market capitalisation today?

Evolus Inc market capitalisation is $0.00T as on .

How to invest in Evolus Inc Stock (EOLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evolus Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evolus Inc Shares that will get you 0.3024 shares as per Evolus Inc share price of $4.96 per share as on April 22, 2026 at 9:42 pm IST.

What is the minimum amount required to buy Evolus Inc Stock (EOLS) from India?

Indian investors can start investing in Evolus Inc (EOLS) shares with as little as ₹93.775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.75 in Evolus Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Evolus Inc share’s latest price of $4.96 as on April 22, 2026 at 9:42 pm IST, you will get 2.0161 shares of Evolus Inc. Learn more about fractional shares .

What are the returns that Evolus Inc has given to Indian investors in the last 5 years?

Evolus Inc stock has given -48.16% share price returns and 23.96% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?